Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series

Pericardial diseases secondary to immune checkpoint inhibitors (ICI) are rare. Here, we describe two cases of immune-related pericarditis caused by ICI for treatment of advanced NSCLC. Select patients can be successfully rechallenged with ICI after immune-related pericardial disease.

Detalles Bibliográficos
Autores principales: Chye, Adrian M., Nordman, Ina I. C., Sverdlov, Aaron L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395697/
https://www.ncbi.nlm.nih.gov/pubmed/36017099
http://dx.doi.org/10.3389/fcvm.2022.964324
Descripción
Sumario:Pericardial diseases secondary to immune checkpoint inhibitors (ICI) are rare. Here, we describe two cases of immune-related pericarditis caused by ICI for treatment of advanced NSCLC. Select patients can be successfully rechallenged with ICI after immune-related pericardial disease.

Ejemplares similares